[Development of a scientific concept for the generation of routine practice data and their analysis for benefit assessments according to §35a Social Code Book (SGB) V in the event of market access for several drugs of one drug class]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018004092
German
Original Title:
Wissenschaftliche Ausarbeitung eines Konzeptes zur Generierung versorgungsnaher Daten und deren Auswertung zum Zwecke der Nutzenbewertung nach § 35a SGB V in der Situation des Marktzugangs mehrerer Arzneimittel einer Wirkstoffklasse
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/a21-37.html
Year Published:
2022
URL for published report:
https://www.iqwig.de/download/a21-37_abd-bei-marktzugang-mehrerer-arzneimittel-einer-wirkstoffklasse_rapid-report_v1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Product Surveillance, Postmarketing
- Immunotherapy, Adoptive
- Drug Evaluation
- Registries
Keywords
- Product Surveillance - Postmarketing
- Registries
- Benefit Assessment
- Concept
- CAR-T cell therapy
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.